XENE
Xenon Pharmaceuticals Inc.
$33.49-0.84 (-2.45%)
Price
MA20
▲Insider buy
▼Insider sell
Loading chart...
Insider Activity
4 of 68 tradesExecutives investing their own money
🤖AI Insight
Latest Insider Transactions
Showing 10 of 68 transactions (past 365 days)
| 1WStock price change 1 week after insider bought. Small number below shows return vs S&P 500. | 1MStock price change 1 month after insider bought. | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-17 | 2026-10-15 | Kelly Thomas Patrick | CFO | Exercise Conversion | 7,500 | $0.00 | $0 | N/A | N/A |
| 2026-10-01 | 2026-09-30 | Kelly Thomas Patrick | CFO | Purchase | 15,000 | $37.32 | $559,740 | -2.4% | N/A |
| 2026-10-01 | 2026-09-30 | Mortimer Ian | CEO | Purchase | 30,000 | $37.38 | $1,121,400 | -2.6% | N/A |
| 2026-09-04 | 2026-09-01 | Svoronos Dawn | Director | Exercise Conversion | 5,144 | $8.15 | $41,924 | N/A | N/A |
| 2026-09-04 | 2026-09-01 | Svoronos Dawn | Director | Exercise Conversion | 5,144 | $8.15 | $41,924 | N/A | N/A |
| 2026-09-01 | 2026-08-28 | Kenney Christopher John | CMO | Sale | 6,368 | $60.17 | $383,143 | N/A | N/A |
| 2026-09-01 | 2026-08-28 | Kenney Christopher John | CMO | Sale | 700 | $60.98 | $42,684 | N/A | N/A |
| 2026-06-09 | 2026-06-05 | Patou Gary | Director | Sale | 1,322 | $53.14 | $70,251 | N/A | N/A |
| 2026-06-09 | 2026-06-05 | Cannon Gillian | Director | Sale | 1,190 | $53.14 | $63,237 | N/A | N/A |
| 2026-06-04 | 2026-06-03 | Patou Gary | Director | Award | 10,507 | $53.46 | $561,704 | N/A | N/A |
XENE
CFO
Exercise Conversion
$0
Kelly Thomas Patrick7,500 shares @ $0.00
Filed 2026-10-17Trade 2026-10-15
XENE
Director
Exercise Conversion
$41.9K
Svoronos Dawn5,144 shares @ $8.15
Filed 2026-09-04Trade 2026-09-01
XENE
Director
Exercise Conversion
$41.9K
Svoronos Dawn5,144 shares @ $8.15
Filed 2026-09-04Trade 2026-09-01
Want to see more transactions?
Sign up for free to unlock more insider transactions and create watchlists.